Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer

[1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2018)Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force JAMA 320 687-705

[3] Siegel RL(2022)Assessing the cervicovaginal microbiota in the context of hrHPV infections: temporal dynamics and therapeutic strategies MBio 13 674-686

[4] Laversanne M(2018)Screening for cervical cancer: US Preventive Services Task Force recommendation statement JAMA 320 169-182

[5] Soerjomataram I(2019)Cervical cancer Lancet 393 378-384

[6] Jemal A(2017)Integrated genomic and molecular characterization of cervical cancer Nature 543 349-375

[7] Melnikow J(2019)Structure and function of Rnt1p: an alternative to RNAi for targeted RNA degradation Wiley Interdiscip Rev RNA 10 51-60

[8] Henderson JT(2019)Sensors and modulators in innate immunity Annu Rev Immunol 37 346-359

[9] Burda BU(2017)The anticancer functions of RIG-I-like receptors, RIG-I and MDA5, and their applications in cancer therapy Transl Res 190 30342-30350

[10] Senger CA(2020)Protein kinase R and its cellular regulators in cancer: an active player or a surveillant? Wiley Interdiscip Rev RNA 11 549-563.e519

[1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2018)Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force JAMA 320 687-705

[3] Siegel RL(2022)Assessing the cervicovaginal microbiota in the context of hrHPV infections: temporal dynamics and therapeutic strategies MBio 13 674-686

[4] Laversanne M(2018)Screening for cervical cancer: US Preventive Services Task Force recommendation statement JAMA 320 169-182

[5] Soerjomataram I(2019)Cervical cancer Lancet 393 378-384

[6] Jemal A(2017)Integrated genomic and molecular characterization of cervical cancer Nature 543 349-375

[7] Melnikow J(2019)Structure and function of Rnt1p: an alternative to RNAi for targeted RNA degradation Wiley Interdiscip Rev RNA 10 51-60

[8] Henderson JT(2019)Sensors and modulators in innate immunity Annu Rev Immunol 37 346-359

[9] Burda BU(2017)The anticancer functions of RIG-I-like receptors, RIG-I and MDA5, and their applications in cancer therapy Transl Res 190 30342-30350

[10] Senger CA(2020)Protein kinase R and its cellular regulators in cancer: an active player or a surveillant? Wiley Interdiscip Rev RNA 11 549-563.e519